3-phosphoglycerate dehydrogenase deficiency in a patient with West syndrome.

Dev Med Child Neurol

S. Neuropediatria i Bioquímica, Unitat Integrada, Hospital Sant Joan de Déu/Hospital Clínic, Universitat de Barcelona, Spain.

Published: September 2000

3-phosphoglycerate dehydrogenase deficiency is a severe but treatable disorder of serine synthesis, first described in 1996 (Jaeken et al. 1996a). The patient presented with West syndrome, severe psychomotor delay, failure to thrive, microcephaly, atypical ocular movements, and pyramidal signs. Treatment with oral L-serine abolished seizures and improved psychomotor development, hyperexcitability, head growth, cortical and subcortical hypotrophy, and hypomyelination of the brain on MRI scans. 3-phosphoglycerate dehydrogenase deficiency is a treatable congenital error that probably leads to West syndrome.

Download full-text PDF

Source
http://dx.doi.org/10.1017/s0012162200001171DOI Listing

Publication Analysis

Top Keywords

3-phosphoglycerate dehydrogenase
12
dehydrogenase deficiency
12
west syndrome
12
deficiency patient
4
patient west
4
syndrome 3-phosphoglycerate
4
deficiency severe
4
severe treatable
4
treatable disorder
4
disorder serine
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!